Clear Impact logo

Vermont Medicaid/CHIP (CCS-MY)

Logo

LSC: Lead Screening in Children - Age 2 (CCS-MY)

Current Value

79.1%

MY 2023

Definition

Line Bar

Notes on Methodology

  • This is a Healthcare Effectiveness & Data Information Set (HEDIS®) administrative measure and only includes Medicaid Primary beneficiaries.
  • The annual reported rate captures activity during the stated measurement year (MY).

The Healthcare Effectiveness Data and Information Set (HEDIS®) is a registered trademark of NCQA.

Story Behind the Curve

This measure assesses the percentage of children 2 years of age who received one or more capillary or venous blood tests for lead poisoning on or before their second birthday.

The National Health and Nutrition Examination Survey, an ongoing series of cross-sectional surveys on the health and nutrition of the U.S. population, reports on the blood lead levels of children and adults. Children 1–5 years of age have the highest prevalence of elevated blood lead levels of any age group in the U.S., although the prevalence has declined over the past several decades. Even with these decreases, an estimated 310,000 children in this country remain at risk for exposure to harmful levels of lead.33F[1] Blood lead levels of African American children and among low-income families remain significantly higher than those of other races and those of other income status.

[1]   CDC. May 2005. “Blood Lead Levels—United States, 1999–2002.” MMWR Morbidity & Mortality Weekly Report 54(20):513–16.

Last updated:  August 2024

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy